HCP (HCP) Tops Q4 FFO by 2c

Go back to HCP (HCP) Tops Q4 FFO by 2c

Stifel Downgrades HCP (HCP) to Sell

February 11, 2016 7:17 AM EST

Stifel downgraded HCP (NYSE: HCP) from Hold to Sell with a price target of $23.00.

For an analyst ratings summary and ratings history on HCP click here. For more ratings news on HCP click here.

Shares of HCP closed at $27.21 yesterday.

... More

UBS Cuts Price Target on HCP, Inc. (HCP) as HCR ManorCare (HCRMC) Faces Difficulties

February 10, 2016 10:36 AM EST

UBS maintained a Buy rating on HCP (NYSE: HCP), and cut the price target to $31.00 (from $41.00). UBS estimates a 30% rent cut would improve coverage fixed charge coverage to 1.4x-1.5x at HRCMC, versus the ~1.1x in guidance for 2016. The higher coverage would provide... More

Hilliard Lyons Downgrades HCP (HCP) to Long-Term Buy

February 10, 2016 9:44 AM EST

Hilliard Lyons downgraded HCP (NYSE: HCP) from Buy to Long-Term Buy.

For an analyst ratings summary and ratings history on HCP click here. For more ratings news on HCP click here.

Shares of HCP closed at $28.33 yesterday.

... More

Mizuho Securities Remains Neutral on HCP, Inc. (HCP) - Cuts PT to $26

February 10, 2016 8:15 AM EST

Mizuho Securities reiterated a Neutral rating on HCP (NYSE: HCP), and cut the price target to $26.00 (from $37.00). Mizuho believes that HCP is a sideways mover for now, with some possible volatility related to the sell-off on Wednesday. Mizuho analysts remain negatively-biased, despite... More